Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11964023 Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates

Patent 11964023 was granted and assigned to Merck Sharp & Dohme Limited on April, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Merck Sharp & Dohme Limited

Current Assignee

Merck Sharp & Dohme Limited

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

119640230

Patent Inventor Names

Yadong Adam Cui0

Michael J. Kosinski0

Luwy Kavuka Musey0

Richard J. Porambo0

Chitrananda Abeygunawardana0

Date of Patent

April 23, 2024

Patent Application Number

178484620

Date Filed

June 24, 2022

Patent Citations

‌

US Patent 9255157 Rhamno-polysaccharide from

‌

US Patent 10406220 Pneumococcal dosing regimen

‌

US Patent 9669084 Pneumococcal dosing regimen

‌

US Patent 8192746 15-valent pneumococcal polysaccharide-protein conjugate vaccine composition

‌

US Patent 8440815 Pneumococcal serotype 6D

‌

US Patent 8481054 Pneumococcal serotypes

‌

US Patent 8808707 Pneumococcal dosing regimen

‌

US Patent 8945568 Pneumococcal Serotype 6D

Patent Primary Examiner

CPC Code

Patent abstract

The present invention provides capsular polysaccharides from

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11964023 Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API